Gene: SYDE2
Official Full Name: synapse defective Rho GTPase homolog 2provided by HGNC
Gene Summary: Predicted to enable GTPase activator activity. Acts upstream of or within cell migration. Predicted to be located in cytosol. Predicted to be active in synaptic membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25163 | SYDE2 Knockout cell line (HeLa) | Human | SYDE2 | 1:3~1:6 | Negative | Online Inquiry |
KO25164 | SYDE2 Knockout cell line (HCT 116) | Human | SYDE2 | 1:2~1:4 | Negative | Online Inquiry |
KO25165 | SYDE2 Knockout cell line (HEK293) | Human | SYDE2 | 1:3~1:6 | Negative | Online Inquiry |
KO25166 | SYDE2 Knockout cell line (A549) | Human | SYDE2 | 1:3~1:4 | Negative | Online Inquiry |
SYDE2 Gene Knockout Cell Lines are a pioneering biological tool designed for advanced genetic research and functional studies. These cell lines are specifically engineered to have a complete knockout of the SYDE2 gene, offering researchers a unique opportunity to investigate the biological role of this gene and its implications in various cellular processes. By utilizing CRISPR/Cas9 technology, these knockout cell lines ensure precise gene editing with high efficiency and specificity, leading to predictable and reproducible results.
The primary function of SYDE2 Gene Knockout Cell Lines is to facilitate the exploration of gene function, regulation, and interaction within cellular systems. This is particularly crucial for investigating SYDE2's involvement in cellular signaling pathways, apoptosis, and development, which can shed light on its contribution to diseases such as cancer and neurodegeneration. Researchers can utilize these cell lines for diverse applications, including drug screening, gene therapy development, and understanding disease mechanisms at the molecular level.
The scientific importance of SYDE2 Gene Knockout Cell Lines extends into translational research and clinical applications, providing a robust platform for the identification of novel therapeutic targets. Compared to traditional knockdown approaches, which can result in incomplete gene suppression and off-target effects, the complete knockout achieved with these cell lines provides a more reliable foundation for experimental outcomes.
Additionally, SYDE2 Gene Knockout Cell Lines present considerable advantages, including user-friendly protocols for cell culture and robust performance in various assays, making them accessible for both experienced and novice researchers. Their versatility allows for adaptation across multiple research disciplines, enhancing their utility in laboratories focused on genomics, developmental biology, and pharmacology.
Ultimately, the value of SYDE2 Gene Knockout Cell Lines lies in their potential to unlock new frontiers in genetic research and therapeutic development. When combined with our company's extensive expertise in genetic engineering and cell line development, customers can rely on the quality and reliability of our biological products to accelerate their research and drive scientific breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.